News Detail
Mumbai, 10 March 2025: Sun Pharmaceuticals on Monday announced that it is set to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million. The transaction is expected to be completed in the second calendar quarter of 2025.
Source : Sun Pharma Press Release
Sun Pharmaceuticals acquisition
Checkpoint Therapeutics
UNLOXCYT approval
immunotherapy and targeted oncology
FDA-approved treatment for cSCC
Dilip Shanghvi statement
checkpoint stockholder cash payment
Sun Pharmaceuticals
Related News
- Congress MP raises issue of bogus medicines in Maha Govt hospitals in Lok Sabha (10-03-2025)
- Odisha sees surge in fake medicines; 4 suppliers blacklisted in 3 years: Dr. Mukesh Mahaling in Assembly (10-03-2025)
- CCRAS signed MoU with SNPS Jadavpur for advancing Ayurveda research in diabetes management (10-03-2025)
- Diabetes Medicine 'Empagliflozin' Will Soon Cost Just Rs 9 (10-03-2025)
- Action impact against quack doctors short-lived, lasting only four days, illegal clinics have resumed operations (10-03-2025)
- Ayushman medicine scam unearthed at PGI (10-03-2025)
- NPPA to consider other sources also to fix ceiling prices of some formulations (10-03-2025)
- FDI equity inflow into pharma sector declines 12% in first nine months of FY25 (10-03-2025)
- Over 100 MSME drug firms modernizing their pharma unit as per WHO standards (10-03-2025)
- Abohar: Operator Arrested After Recovery of One Thousand Banned Capsules, No License Found (09-03-2025)